The effects of bisphosphonate zoledronic acid in hepatocellular carcinoma, depending on mevalonate pathway-Reference-Cited by-同舟云学术

The effects of bisphosphonate zoledronic acid in hepatocellular carcinoma, depending on mevalonate pathway

Published:2015-02-23 Issue:3 Volume:30 Page:619-627
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Honda Yohji¹,Takahashi Shoichi¹,Zhang Yizhou¹,Ono Atsushi¹,Murakami Eisuke¹,Shi Niu¹,Kawaoka Tomokazu¹,Miki Daiki¹,Tsuge Masataka¹,Hiraga Nobuhiko¹,Abe Hiromi¹,Ochi Hidenori¹,Imamura Michio¹,Aikata Hiroshi¹,Chayama Kazuaki¹

Affiliation:

1. Department of Medicine and Molecular Science; Hiroshima University; Hiroshima Japan

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.12715/fullpdf

Reference33 articles.

1. Recent progress in the management of hepatocellular carcinoma detected during a surveillance program in Japan;Nakano;Hepatol. Res.,2010

2. Management of hepatocellular carcinoma: report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009);Arii;Hepatol. Res.,2010

3. Management of hepatocellular carcinoma in Japan;Okita;J. Gastroenterol.,2006

4. Pretreatment predictor of response, time to progression, and survival to intraarterial 5-fluorouracil/interferon combination therapy in patients with advanced hepatocellular carcinoma;Uka;J. Gastroenterol.,2007

5. Combination of transcatheter arterial chemoembolozation using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma;Kamada;Am. J. Surg.,2002

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. M4IDP stimulates ROS elevation through inhibition of mevalonate pathway and pentose phosphate pathway to inhibit colon cancer cells;Biochemical Pharmacology;2023-11

2. Biological characteristics of γδT cells and application in tumor immunotherapy;Frontiers in Genetics;2023-01-04

3. Clinical Outcomes of Switching from Zoledronic Acid to Denosumab for the Management of Severe Bone Metastasis from Hepatocellular Carcinoma: A Single-Center, Open-Label, Prospective Intervention Trial;Yonago Acta Medica;2023

4. M4idp Stimulates ROS Elevation Through Inhibition of Mevalonate Pathway and Pentose Phosphate Pathway to Inhibit Colon Cancer Cells;2023

5. Bone metastasis of hepatocellular carcinoma: facts and hopes from clinical and translational perspectives;Frontiers of Medicine;2022-07-19